SecBot SecBot
25-NSE ·Filed Nov 17, 2026

PCRX

Pacira BioSciences, Inc.
NEUTRAL
Impact 1/10
Horizonimmediate Processed4d 22h ago SEC0001354457-26-001084
Notable filing: 25-NSE
Actionable Insight • Neutral

This filing confirms the common stock has been removed from Nasdaq. Monitor for any subsequent corporate action (e.g., merger close, buyout completion, or dissolution) that triggered the redemption or retirement.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Nasdaq filed a Form 25-NSE to delist Pacira BioSciences' common stock under Rule 12d2-2(a)(3), which covers matured, redeemed, or retired securities. This is a routine administrative removal of a security that no longer trades, not a forced delisting or bankruptcy event.

Key Facts

  • Form 25-NSE filed by Nasdaq Stock Market LLC on 2026-11-17
  • Security removed: common stock of Pacira BioSciences, Inc.
  • Rule cited: 17 CFR 240.12d2-2(a)(3), matured, redeemed, or retired securities
  • Effectiveness date: 2026-11-17
  • Subject company contact: 5 Sylvan Way, Suite 125, Parsippany, NJ

Financial Impact

No financial impact; the filing is an administrative notice of delisting for a security that has been redeemed or retired.

Risk Factors

  • No material risk identified; this is a routine post-event notification.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
25-NSE Filing (Primary)0001354457-26-001084
Document: 0001354457-26-001084-index-headers.html0001354457-26-001084
Document: 0001354457-26-001084-index.html0001354457-26-001084
Document: 0001354457-26-001084.txt0001354457-26-001084

Track record

33 reports on PCRX

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +42.26% at T+60 after the Aug 6, 2026 report. 8 of 9 went positive at some point.

Filters
  1. Nov 17, 20264d ago 8-K Mixed 8/10 Entry $36.48 Now $36.48 −0.00% settles Dec 16
  2. Nov 17, 20264d ago SC 14D-9/A Mixed 8/10 Entry $36.48 Now $36.48 −0.00% settles Dec 16
  3. Nov 17, 20264d ago SC TO-T/A Mixed 7/10 Entry $36.48 Now $36.48 −0.00% settles Dec 16
  4. Nov 17, 20264d ago 25-NSE Neutral 1/10 Viewing Entry $36.48 Now $36.48 −0.00% settles Dec 16
  5. Nov 12, 20269d ago 8-K Bearish 6/10 Entry $36.46 Now $36.48 −0.05% settles Dec 14
  6. Nov 12, 20269d ago SC TO-T/A Mixed 7/10 Entry $36.46 Now $36.48 +0.05% settles Dec 14
  7. Nov 12, 20269d ago SC 14D-9/A Neutral 3/10 Entry $36.46 Now $36.48 +0.05% settles Dec 14
  8. Nov 5, 202616d ago 8-K Neutral 5/10 Entry $36.43 Now $36.48 +0.14% settles Dec 7
  9. Nov 3, 202618d ago SC 14D-9/A Neutral 3/10 Entry $36.40 Now $36.48 +0.22% settles Dec 3
  10. Oct 30, 202622d ago SC 13G/A Neutral 2/10 Entry $36.39 Now $36.48 +0.25% settles Nov 30
Showing 10 of 33

US Market Status

Market Closed · Opens Mon (25h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 17, 2026